J. Zhao, Y. Lian, C. Lu, L. Jing, H. Yuan, S. Peng: Inhibitory effects of a bisbenzylisoquinline alkaloid dauricine on HERG potassium channels. In: Journal of ethnopharmacology. Band 141, Nummer 2, Juni 2012, S. 685–691, doi:10.1016/j.jep.2011.08.054, PMID 21920426.
Z. Yang, C. Li, X. Wang, C. Zhai, Z. Yi, L. Wang, B. Liu, B. Du, H. Wu, X. Guo, M. Liu, D. Li, J. Luo: Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. In: Journal of cellular physiology. Band 225, Nummer 1, Oktober 2010, S. 266–275, doi:10.1002/jcp.22261, PMID 20509140.
H. Jin, J. Dai, X. Chen, J. Liu, D. Zhong, Y. Gu, J. Zheng: Pulmonary toxicity and metabolic activation of dauricine in CD-1 mice. In: The Journal of pharmacology and experimental therapeutics. Band 332, Nummer 3, März 2010, S. 738–746, doi:10.1124/jpet.109.162297, PMID 20008063.
X. D. Tang, X. Zhou, K. Y. Zhou: Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells. In: Acta pharmacologica Sinica. Band 30, Nummer 5, Mai 2009, S. 605–616, doi:10.1038/aps.2009.8, PMID 19349962, PMC 4002832 (freier Volltext).
H. Xie, Y. Liu, Y. Peng, D. Zhao, J. Zheng: Detection of protein adduction derived from dauricine by alkaline permethylation. In: Analytical and bioanalytical chemistry. Band 408, Nummer 15, Juni 2016, S. 4111–4119, doi:10.1007/s00216-016-9505-0, PMID 27071763.
F. M. Han, Z. H. Peng, W. Song, H. M. Zhang, M. M. Zhu, Y. Chen: Identification of dauricine and its metabolites in rat urine by liquid chromatography-tandem mass spectrometry. In: Journal of Chromatography B. Band 854, Nummer 1–2, Juli 2007, S. 1–7, doi:10.1016/j.jchromb.2007.03.036, PMID 17448738.
nih.gov
ncbi.nlm.nih.gov
J. Q. Qian: Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. In: Acta pharmacologica Sinica. Band 23, Nummer 12, Dezember 2002, S. 1086–1092, PMID 12466045.
K. Y. Feng, C. J. Hu, J. A. Zhou: [Clinical observations on sustained arrhythmias treated with dauricine]. In: Zhonghua xin xue guan bing za zhi. Band 12, Nummer 4, Dezember 1984, S. 265–7, 315, PMID 6544209.
J. Zhao, Y. Lian, C. Lu, L. Jing, H. Yuan, S. Peng: Inhibitory effects of a bisbenzylisoquinline alkaloid dauricine on HERG potassium channels. In: Journal of ethnopharmacology. Band 141, Nummer 2, Juni 2012, S. 685–691, doi:10.1016/j.jep.2011.08.054, PMID 21920426.
Z. Yang, C. Li, X. Wang, C. Zhai, Z. Yi, L. Wang, B. Liu, B. Du, H. Wu, X. Guo, M. Liu, D. Li, J. Luo: Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. In: Journal of cellular physiology. Band 225, Nummer 1, Oktober 2010, S. 266–275, doi:10.1002/jcp.22261, PMID 20509140.
H. Jin, J. Dai, X. Chen, J. Liu, D. Zhong, Y. Gu, J. Zheng: Pulmonary toxicity and metabolic activation of dauricine in CD-1 mice. In: The Journal of pharmacology and experimental therapeutics. Band 332, Nummer 3, März 2010, S. 738–746, doi:10.1124/jpet.109.162297, PMID 20008063.
X. D. Tang, X. Zhou, K. Y. Zhou: Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells. In: Acta pharmacologica Sinica. Band 30, Nummer 5, Mai 2009, S. 605–616, doi:10.1038/aps.2009.8, PMID 19349962, PMC 4002832 (freier Volltext).
H. Xie, Y. Liu, Y. Peng, D. Zhao, J. Zheng: Detection of protein adduction derived from dauricine by alkaline permethylation. In: Analytical and bioanalytical chemistry. Band 408, Nummer 15, Juni 2016, S. 4111–4119, doi:10.1007/s00216-016-9505-0, PMID 27071763.
F. M. Han, Z. H. Peng, W. Song, H. M. Zhang, M. M. Zhu, Y. Chen: Identification of dauricine and its metabolites in rat urine by liquid chromatography-tandem mass spectrometry. In: Journal of Chromatography B. Band 854, Nummer 1–2, Juli 2007, S. 1–7, doi:10.1016/j.jchromb.2007.03.036, PMID 17448738.